Blockade of eosinophil migration and airway hyperresponsiveness by cPLA2-inhibition

Nature Immunology

Volumn 2, Issue 2, 2001, Pages 145-149

  Myou, Shigeharu ^a   Sano, Hiroyuki ^b   Fujimura, Masaki ^a   Zhu, Xiangdong ^b   Kurashima, Kazuyoshi ^a   Kita, Toshiyuki ^a   Nakao, Shinji ^a   Nonomura, Akitaka ^c   Shioya, Takanobu ^b   Kim, Kwang Pyo ^d   Munoz, Nilda M ^b   Cho, Wonhwa ^d   Left, Alan R ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF CHICAGO   (United States)

^c KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 (2 CHLOROPHENYL) 9 CYCLOPROPYLCARBONYL 7,8,9,10 TETRAHYDRO 1,4 DIMETHYL 4H PYRIDO[4',3':4,5]THIENO[3,2 F][1,2,4]TRIAZOLO[4,3 A][1,4]DIAZEPINE; ANTIGEN; AZEPINE DERIVATIVE; BENZOQUINONE DERIVATIVE; BUTYROPHENONE DERIVATIVE; DOCEBENONE; DRUG DERIVATIVE; EBASTINE; ENZYME INHIBITOR; EPACOCF3; ICOSAPENTAENOIC ACID; INDOMETACIN; METHACHOLINE CHLORIDE; PHOSPHOLIPASE A; PIPERIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANIMAL; ARTICLE; BRONCHOSPASM; DRUG ANTAGONISM; DRUG EFFECT; EOSINOPHIL; GUINEA PIG; IMMUNOLOGY; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RESPIRATORY TRACT ALLERGY;

ANIMALS; ANTIGENS; AZEPINES; BENZOQUINONES; BRONCHOCONSTRICTION; BUTYROPHENONES; EICOSAPENTAENOIC ACID; ENZYME INHIBITORS; EOSINOPHILS; GUINEA PIGS; INDOMETHACIN; MALE; METHACHOLINE CHLORIDE; PHOSPHOLIPASES A; PIPERIDINES; RESPIRATORY HYPERSENSITIVITY; TRIAZOLES;

EID: 7044263406     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/84244     Document Type: Article

References (45)

1. Bousquet, J. et al. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323, 1033-1039 (1990).
2. Laitinen, L.A., Laitinen,A. & Haahtela, T.Airway mucosal inflammation even in patients with newly diagnosed asthma. Am. Rev. Respir. Dis. 147, 697-704 (1993).
3. Uozumi, N. et al. Role of cytosolic phospholipase A2 in allergic response and parturition. Nature 390, 618-622 (1997).
4. 2. Nature Immunol. 1, 42-46 (2000).
5. Irvine, R. F. How is the level of free arachidonic acid controlled in mammalian cells? Biochem. J. 204, 3-16 (1982).
6. Hanahan, D. J. Platelet activating factor: a biologically active phosphoglyceride. Annu. Rev. Biochem. 55, 483-509 (1986).
7. Barnes, P. J. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J.Allergy Clin. Immunol. 83, 1013-1026 (1989).
8. Richards, I. M. et al. Contribution of leukotriene B4 to airway inflammation and the effect of antagonists. Ann. NY Acad. Sci. 629, 274-287 (1991).
9. Powell,W. S., Chung, D. & Gravel, S. 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of human eosinophil migration. J. Immunol. 154, 4123-4132 (1995).
10. Cuss, F. M., Dixon, C. M. & Barnes, P.J. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet 2, 189-192 (1986).
11. Weiss, J.W. et al. Bronchoconstrictor effects of leukotriene C in humans. Science 216, 196-198 (1982).
12. Fischer, A. R. et al. Effect of chronic 5-lipoxygenase inhibition on airway hyperresponsiveness in asthmatic subjects. Am. J. Respir. Crit. Care Med. 152, 1203-1207 (1995).
13. Fuller, R. W., Dixon, C. M., Dollery, C.T. & Barnes, P.J. Prostaglandin D2 potentiates airway responsiveness to histamine and methacholine. Am. Rev. Respir. Dis. 133, 252-254 (1986).
14. Jones, G. L., Saroea, H. G., Watson, R. M. & O'Byrne, P. M. Effect of an inhaled thromboxane mimetic (U46619) on airway function in human subjects. Am. Rev. Respir. Dis. 145, 1270-1274 (1992).
15. 2 integrin-dependent adhesion of human eosinophils. J. Immunol. 163, 3423-3429 (1999).
16. Tsunoda, H. et al. Effects of a novel PAF antagonist. E6123, on PAF-induced biological responses.Agents Actions Suppl. 31, 251-254 (1990).
17. Kaneko,T., Ikeda, H., Fu, L., Nishiyama, H. & Okubo,T. Platelet-activating factor mediates the ozone-induced increase in airway microvascular leakage in guinea pigs. Eur. J. Pharmacol. 292, 251-255 (1995).
18. Ashida,Y. et al. Pharmacological profile o fAA-861, a 5-lipoxygenase inhibitor. Prostoglandins 26, 955-972 (1983).
19. Arima, M.,Yukawa,T. & Makino, S. Effect of YM264 on the airway hyperresponsiveness and the late asthmatic response in a guinea pig model of asthma. Chest 108, 529-534 (1995).
20. Sun, F. F., Czuk, C. I. & Taylor, B. M.Arachidonic acid metabolism in guinea pig eosinophils: synthesis of thromboxane B2 and leukotriene B4 in response to soluble or particulate activators. J. Leukoc. Biol. 46, 152-160 (1989).
21. Hirata, K., Maghni, K., Borgeat, P. & Sirois, P. Guinea pig alveolar eosinophils and macrophages produce leukotriene B4 but no peptido-leukotriene. J. Immunol. 144, 1880-1885 (1990).
22. Sun, F. F. et al. Biochemical and functional differences between eosinophils from animal species and man. J. Leukoc. Biol. 50, 140-150 (1991).
23. Tohda,Y. el al. The inhibitory effect of TMK688, a novel anti-allergic drug having both 5-lipoxygenase inhibitory activity and anti-histamine activity, against bronchoconstriction, leukotriene production and inflammatory cell infiltration in sensitized guinea pigs. Clinn. Exp.Allergy 27, 110-118 (1997).
24. Serhan, C. N. Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a Jungle of cell-cell interactions or a therapeutic opportunity? Prostaglandins 53, 107-137 (1997).
25. Quinn, M.T., Parthasarathy, S. & Steinberg, D. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc. Natl Acad. Sci. USA 85, 2805-2809 (1988).
26. Chilton, F. H. et al. Antigen-induced generation of lyso-phospholipids in human airways. J. Exp. Med. 183, 2235-2245 (1996).
27. Kagoshima, M. et al. Suppressive effects of Y-24180, a receptor antagonist to platelet activating factor (PAF), on antigen-induced asthmatic responses in guinea pigs, Inflamm. Res. 46, 147-153 (1997).
28. Heuer, H. O., Leon, I., Anderson, G. P. & Jennewein, H. M. Comparative effects of a glucocorticosteroid, theophylline and the peptido-leukotriene-antagonist CGP 45715A on antigen-induced early and late phase airway response and inflammatory cell influx in sensitised guinea pigs. Eur. J. Pharmacol. 369, 225-231 (1999).
29. Tsunoda, H. et al. Activity of a novel thienodiazepine derivative as a platelet-activating factor antagonist in guinea pig lungs. Effects on platelet-activating factor and allergen induced eosinophil accumulation. Arzneimittelforschung 41, 224-227 (1991).
30. Fitzgerald, M. F., Moncada, S. & Parente, L.The anaphylactic release of platelet-activating factor from perfused guinea-pig lungs. Br. J. Pharmacol. 88, 149-153 (1986).
31. Uchida,Y. et al. Involvement of endothelins in immediate and late asthmatic responses of guinea pigs. J. Pharmocol. Exp.Ther. 277, 1622-1629 (1996).
32. Henderson,W. R. Jr, Lu, J., Poole, K. M., Dietsch, G. N. & Chi, E.Y. Recombinant human platelet-activating factor-acetylhydrolase inhibits airway inflammation and hyperreactivity in mouse asthma model. J. Immunol. 164, 3360-3367 (2000).
33. Kuitert, L. M. et al. Effect of a novel potent platelet-activating factor antagonist, modipafant, in clinical asthma. Am. J. Respir. Crit. Care Med. 151, 1331-1335 (1995).
34. Evans, D. J., Barnes, P. J., Cluzel, M. & O'Connor, B. J. Effects of a potent platelet-activating factor antagonist, 5R27417A, on allergen-induced asthmatic responses. Am. J. Respir. Crit. Care Med. 156, 11-16 (1997).
35. Henig, N. R.,Aitken, M. L., Liu, M. C.,Yu,A. S. & Henderson,W. R. Jr Effect of recombinant human platelet-activating factor-acetylhydrolase on allergen-induced asthmatic responses. Am. J. Respir. Crit. Care Med. 162, 523-527 (2000).
36. Andersson, P. Antigen-induced bronchial anaphylaxis in actively sensitized guinea pigs.The effect of booster injection and cyclophosphamide treatment. Int.Arch.Allergy Appl. Immunol. 64, 249-258 (1981).
37. Street, I. P. et al. Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2. Biochemistry 32, 5935-5940 (1993).
38. Yoshimoto,T. et al. 2,3,5-Trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone (AA861), a selective inhibitor of the 5-lipoxygenase reaction and the biosynthesis of slow-reacting substance of anaphylaxis. Biochim. Biophys.Acta 713, 470-473 (1982).
39. Pennock, B. E., Cox, C. P., Rodgers, R. M., Cain,W.A. & Wells, J. H.A non-invasive technique for the measurement of change in specific airway resistance. J. Appl. Physiol. 46, 399-406 (1996).
40. Fryer, A. D. et al. Antibody to VLA-4, but not to L-selectin, protects neuronal M2 muscarinic receptors in antigen-challenged guinea pig airways. J. Clin. Invest. 99, 2036-2044 (1997).
41. Evans, C. M., Fryer,A. D., Jacoby, D. B., Gleich, G. J. & Costello, R.W. Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. J. Clin. Invest. 100, 2254-2262 (1997).
42. Konzett, H. & Roessler, R. Versuchanordnungzu Untersuchungen an der Bronchialmusukulatur. Arch. Exp. Poth. Phormak. 195, 71-74 (1940).
43. Jones,T. et al. Biological activity of leukotriene sulfones of respiratory tissues. Prostaglandins 24, 279-289 (1982).
44. Minami, S. et al. A new quantitative inhalation apparatus for small animals. Jpn. J. Chest Dis. 21, 252-258 (1982).
45. Kurashima, K., Fujimura, M.,Tsujiura, M. & Matsuda,T. Effect of surfactant inhalation on allergic bronchoconstriction in guinea pigs. Clin. Exp.Allergy 27, 337-342 (1997).